ONHS Report: HT942526VRPTRA

DoW Vision, Translational Research Award

Solicitation ID: HT942526VRPTRA

Agency: DHA

Type: Grant

Deadline: 2026-11-12T00:00:00 ET

Eligibility: Yes (Unrestricted)

Funding: Approximately $1.6M to fund one award, with a total cost cap of $1.6M for a 3-year performance period.

Doc Type: BAA

Clearance: No

Program Manager: help@eBRAP.org

Last Updated: 2026-08-19 14:59

Analyzed File: HT942526VRPTRA_GG.pdf

Eligibility Reasoning

Extramural and intramural U.S. Department of War (DOW) organizations are eligible to apply, including foreign and domestic organizations, for-profit and nonprofit organizations, and public or private entities... Applications from investigators within the DOW and applications involving multidisciplinary collaborations among academia, industry, the DOW, the U.S. Department of Veterans Affairs (VA) and other federal government agencies are highly encouraged.

Note: This is an AI-generated summary...

Summary

The Fiscal Year 2026 (FY26) Vision Research Program (VRP) Translational Research Award (TRA) supports translational research aimed at transforming promising discoveries into new drugs, devices, or clinical practice guidelines that are prepared for definitive testing in clinical trials. This award may fund preclinical studies, clinical research, or a pilot clinical trial, but not a full-scale clinical trial. Proposed research must align with at least one of the FY26 VRP Focus Areas, which include treating military-related eye injury/visual dysfunction, diagnosis and treatment in austere environments, and restoring visual function. The award has a total cost cap of $1.6 million over a maximum 3-year period of performance. Distinctive features include a Partnering Principal Investigator (PI) Option for two PIs and a requirement for regulatory expertise on teams developing new drugs or devices. Applications are evaluated based on research idea, strategy, feasibility, impact, personnel, a post-award transition plan, and relevance to military health.

Overall Technical Areas

Translational Medical ResearchVision Science ResearchOcular Trauma ResearchTraumatic Brain Injury (TBI) ResearchTherapeutic Drug DevelopmentMedical Device DevelopmentClinical Practice Guideline DevelopmentPilot Clinical Trial DesignClinical Research MethodologyPreclinical Animal ModelsIn Vitro & Organoid ModelsRegulatory Science (IND/IDE)Good Laboratory/Clinical Practices (GLP/GCP)Biostatistical AnalysisVisual Function Restoration

Probable LBNL Areas

N/A

Focus Areas

Example Priorities:

Understand and treat eye injury or visual dysfunction as related to military exposure
Diagnose, stabilize and treat eye injuries in austere environments and prolonged care settings
Restore visual function after military exposure-related vision loss or severe visual impairment

Specific Technical Skills:

Understand and treat eye injury or visual dysfunction as related to military exposureDiagnose, stabilize and treat eye injuries in austere environments and prolonged care settingsRestore visual function after military exposure-related vision loss or severe visual impairment

Potential PIs for this Area:

Name	Score	Organization

Potential LBNL PIs (Overall)

Note on PI Matching: These suggestions are generated through an AI-driven semantic analysis of LBNL staff profiles.

Name	Score	Organization
Jennifer Rosenbluth	0.75	· In Vitro & Organoid Models
Karthik Shekhar	0.73	BSA \| Biological Systems & Engineering \| Biodesign Dept · Vision Science Research
Peter Tennessen	0.73	PSA \| Engineering \| Mechanical Engineering · Medical Device Development
Reginald Lee	0.71	PSA \| Engineering \| Mechanical Engineering · Medical Device Development
Carolyn Larabell	0.71	BSA \| Molecular Biophysics & Integrated Bioimaging \| Bioenergetics Dept · Good Laboratory/Clinical Practices (GLP/GCP)
Zixi Hu	0.71	CSA \| AMCR \| Mathematics · Biostatistical Analysis
Kevin Fan	0.71	LD \| LD \| Strategic Partnerships · Traumatic Brain Injury (TBI) Research
Gerard Marriott	0.71	BSA \| Molecular Biophysics & Integrated Bioimaging \| Cellular & Tissue Image · Ocular Trauma Research
Jian-Hua Mao	0.71	BSA \| Biological Systems & Engineering \| Department of BioEngineering and BioMedical Sciences · Preclinical Animal Models
Aris Polyzos	0.70	BSA \| Molecular Biophysics & Integrated Bioimaging \| Cellular & Tissue Image · Therapeutic Drug Development

Fundamental Research Exemption (FRE)

In accordance with National Security Presidential Memorandum-33 and all associated laws, all fundamental research funded by the DOW must be evaluated for affiliations with foreign entities.